- Home
- ARR vs OMCL Comparison
ARR vs OMCL Comparison
Compare ARR & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARR | OMCL |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Computer Manufacturing |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | ARR | OMCL |
|---|---|---|
| Price | $17.10 | $37.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $18.50 | ★ $55.83 |
| AVG Volume (30 Days) | ★ 2.7M | 476.6K |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | ★ 16.69% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $787,309,000.00 |
| Revenue This Year | N/A | $6.77 |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ $27.18 | $151.28 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $13.98 | $26.85 |
| 52 Week High | $19.31 | $51.84 |
Technical Indicators
Market Signals| Indicator | ARR | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 51.10 | 35.32 |
| Support Level | $17.04 | $35.44 |
| Resistance Level | $17.24 | $45.06 |
| Average True Range (ATR) | 0.26 | 1.75 |
| MACD | 0.02 | -0.83 |
| Stochastic Oscillator | 74.07 | 17.63 |
Price Performance
Historical ComparisonAbout ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.